0001213900-26-036424
SEC filingAdvanced Biomed Inc. announced the resignation of Steven I-Fang Cheng as Director and CTO and the concurrent appointment of CFO Mingze Yin to the Board of Directors, effective March 25, 2026.
The filing details a transition in the board composition and executive leadership of Advanced Biomed Inc. Steven I-Fang Cheng departed from his positions as a member of the Board of Directors and Chief Technology Officer on March 25, 2026. The company explicitly stated that the resignation was not the result of a disagreement concerning operations, policies, or practices, suggesting an amicable separation. Concurrently, the Board filled the resulting vacancy by appointing Mingze Yin, who currently serves as the Chief Financial Officer, as a director. This appointment, effective immediately on March 25, 2026, followed the standard governance process via the recommendation of the Nominating Committee. The disclosure confirmed the absence of familial ties or undisclosed arrangements involving Mr. Yin, ensuring compliance with standard corporate governance transparency requirements.